Savara Inc Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
Savara Inc (SVRA) had Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax of $55.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2020-11-05
- 2020-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $55.00K.
- 2020-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $151.00K.
- 2020-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $127.00K.
- 2019-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $51.00K.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2020-09-30 | $55.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $151.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $127.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $51.00K 10-Q · filed 2020-11-05 |
| 2019-09-30 | $103.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $115.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $20.00K 10-Q · filed 2019-05-09 |
| 2018-09-30 | $1.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.00K 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |